Structures by: Chang J.
Total: 179
C31H27NO6S
C31H27NO6S
Organic letters (2016) 18, 19 5022-5025
a=9.6744(19)Å b=11.557(2)Å c=12.090(2)Å
α=86.67(3)° β=80.45(3)° γ=87.22(3)°
C32H29NO6S
C32H29NO6S
Organic letters (2016) 18, 19 5022-5025
a=11.089(2)Å b=21.075(4)Å c=12.128(2)Å
α=90.00° β=97.24(3)° γ=90.00°
C31H25NO7S
C31H25NO7S
Organic letters (2016) 18, 19 5022-5025
a=10.0018(6)Å b=11.5034(6)Å c=12.0989(6)Å
α=88.001(2)° β=75.075(2)° γ=78.255(2)°
C31H27NO6S
C31H27NO6S
Organic letters (2016) 18, 19 5022-5025
a=10.8777(3)Å b=11.0084(3)Å c=13.1029(4)Å
α=112.4340(10)° β=105.6650(10)° γ=98.6310(10)°
C17H20FNO4S
C17H20FNO4S
Organic letters (2016) 18, 16 3984-3987
a=8.5007(9)Å b=10.2500(12)Å c=11.2985(15)Å
α=75.804(10)° β=70.345(11)° γ=81.631(9)°
C41H39N3O4S2
C41H39N3O4S2
Organic letters (2016) 18, 14 3390-3393
a=38.8089(12)Å b=9.9944(3)Å c=20.8313(7)Å
α=90.00° β=111.9150(10)° γ=90.00°
9b-(2-bromobenzyl)-5-methyl-5,9b-dihydropyrrolizino[3,2-b]indol-10(4aH)-one
C21H17BrN2O
Organic Chemistry Frontiers (2018) 5, 1 80
a=8.7889(18)Å b=8.9182(18)Å c=22.444(5)Å
α=90.00° β=91.02(3)° γ=90.00°
C30H28N4O2
C30H28N4O2
Organic Chemistry Frontiers (2018) 5, 1 80
a=9.8465(5)Å b=26.3558(14)Å c=9.9725(5)Å
α=90.00° β=104.267(2)° γ=90.00°
C23H31FN3O10P
C23H31FN3O10P
Journal of medicinal chemistry (2016) 59, 8 3661-3670
a=30.024(6)Å b=7.0591(14)Å c=13.290(3)Å
α=90.00° β=101.32(3)° γ=90.00°
C372H294Cl12F36N30O90Zn6
C372H294Cl12F36N30O90Zn6
Nature Chemistry (2017) 9, 128-134
a=33.7737(7)Å b=19.1957(5)Å c=37.7788(7)Å
α=90° β=101.142(2)° γ=90°
C222H198F24N24O24
C222H198F24N24O24
Nature Chemistry (2017) 9, 128-134
a=19.6706(5)Å b=22.8014(5)Å c=25.4507(5)Å
α=99.269(2)° β=107.063(2)° γ=106.023(2)°
C190H147Cl6F18N20O44Zn3
C190H147Cl6F18N20O44Zn3
Nature Chemistry (2017) 9, 128-134
a=12.1557(5)Å b=24.1339(10)Å c=39.3371(9)Å
α=85.206(2)° β=87.550(2)° γ=75.675(4)°
C194H201Cl8N27O54Zn4
C194H201Cl8N27O54Zn4
Nature Chemistry (2017) 9, 128-134
a=20.5708(8)Å b=21.4332(8)Å c=24.3151(8)Å
α=92.087(3)° β=91.400(3)° γ=112.299(4)°
C18H14F2O2
C18H14F2O2
Organic letters (2017)
a=6.572(5)Å b=9.090(5)Å c=12.884(5)Å
α=77.172(5)° β=75.946(5)° γ=79.191(5)°
C42H50S2Si2
C42H50S2Si2
Chem. Sci. (2014) 5, 11 4490
a=7.402(6)Å b=14.535(11)Å c=18.955(14)Å
α=73.693(15)° β=83.913(16)° γ=77.680(14)°
C38H30S2
C38H30S2
Chem. Sci. (2014) 5, 11 4490
a=7.0732(12)Å b=7.9974(14)Å c=12.843(2)Å
α=83.771(13)° β=88.008(13)° γ=79.973(14)°
C40H34S2
C40H34S2
Chem. Sci. (2014) 5, 11 4490
a=24.0560(10)Å b=16.0276(10)Å c=18.3518(16)Å
α=90.00° β=122.105(4)° γ=90.00°
C44H50S3Si2
C44H50S3Si2
Chem. Sci. (2014) 5, 11 4490
a=7.5100(3)Å b=14.0747(6)Å c=20.3192(9)Å
α=73.205(2)° β=81.761(2)° γ=82.646(2)°
C12H15FN6O4
C12H15FN6O4
Journal of medicinal chemistry (2015) 58, 9 3693-3703
a=7.3545(10)Å b=7.3545(10)Å c=27.835(6)Å
α=90.00° β=90.00° γ=90.00°
C40H50SSi2
C40H50SSi2
Chem. Sci. (2014) 5, 11 4490
a=18.8584(12)Å b=12.3701(8)Å c=15.9959(11)Å
α=90.00° β=104.724(4)° γ=90.00°
C21H34O4
C21H34O4
Journal of natural products (2009) 72, 6 1128-1132
a=17.854(10)Å b=7.164(4)Å c=16.135(8)Å
α=90.00° β=107.171(13)° γ=90.00°
C18H27F2NO5
C18H27F2NO5
Journal of medicinal chemistry (2012) 55, 13 6061-6075
a=13.6384(5)Å b=7.1514(3)Å c=19.5985(8)Å
α=90.00° β=101.0480(10)° γ=90.00°
C54H62Cl6N4O4S2
C54H62Cl6N4O4S2
Organic letters (2012) 14, 12 2964-2967
a=5.8840(10)Å b=14.260(3)Å c=17.526(3)Å
α=70.967(2)° β=82.158(2)° γ=86.783(2)°
141208b
C24H21NO4S
Organic letters (2015) 17, 18 4472-4475
a=8.2556(17)Å b=14.406(3)Å c=17.938(4)Å
α=90.00° β=93.63(3)° γ=90.00°
C60H42Co3F20N30O64V2W18,26(H2O)
C60H42Co3F20N30O64V2W18,26(H2O)
CrystEngComm (2020)
a=24.0649(6)Å b=30.3771(7)Å c=18.2553(5)Å
α=90° β=90° γ=90°
C57H77NO6
C57H77NO6
Organic & biomolecular chemistry (2020) 18, 21 4056-4062
a=12.0080(10)Å b=13.0066(10)Å c=34.139(2)Å
α=90° β=90° γ=90°
2-chloro-6-(p-tolyl)phenanthridine
C20H14ClN
Organic & biomolecular chemistry (2020) 18, 17 3312-3323
a=5.5878(7)Å b=10.8004(11)Å c=13.7039(12)Å
α=105.531(8)° β=91.027(9)° γ=101.719(10)°
1,3-diphenylimidazo[1,5-a]pyridine
C19H14N2
Organic & biomolecular chemistry (2018) 16, 31 5653-5660
a=23.8510(10)Å b=7.4217(4)Å c=7.8859(4)Å
α=90° β=90° γ=90°
C24H22N4
C24H22N4
Organic & biomolecular chemistry (2019) 17, 13 3446-3450
a=9.8651(4)Å b=18.4812(9)Å c=11.3374(6)Å
α=90° β=107.506(5)° γ=90°
C66H42Cl12N8S2
C66H42Cl12N8S2
Organic & biomolecular chemistry (2013) 11, 37 6285-6291
a=10.1259(11)Å b=11.1866(13)Å c=15.4918(17)Å
α=102.087(2)° β=91.163(2)° γ=105.935(2)°
C66.5H30.5Cl7.5F12N4
C66.5H30.5Cl7.5F12N4
Organic & biomolecular chemistry (2013) 11, 37 6285-6291
a=13.0937(14)Å b=15.1874(17)Å c=30.448(3)Å
α=90.00° β=98.319(3)° γ=90.00°
4,8-bis(4-phenoxyphenyl)-1,5-naphthyridine
C32H22N2O2
Organic & biomolecular chemistry (2012) 10, 33 6693-6704
a=9.869(2)Å b=14.785(3)Å c=16.173(3)Å
α=90.00° β=95.51(3)° γ=90.00°
4,8-bis(9,9-dibutyl-9H-fluoren-2-yl)-1,5-naphthyridine
C25H27N
Organic & biomolecular chemistry (2012) 10, 33 6693-6704
a=8.9420(18)Å b=10.249(2)Å c=21.626(4)Å
α=90.00° β=96.87(3)° γ=90.00°
4,8-bis(4-(tert-butyl)phenyl)-1,5-naphthyridine
C14H15N
Organic & biomolecular chemistry (2012) 10, 33 6693-6704
a=11.973(2)Å b=7.8020(16)Å c=12.534(3)Å
α=90.00° β=102.95(3)° γ=90.00°
C20H18N2O2
C20H18N2O2
Organic & biomolecular chemistry (2014) 12, 23 3912-3923
a=7.7404(15)Å b=8.6624(17)Å c=13.340(3)Å
α=81.46(3)° β=89.70(3)° γ=70.47(3)°
IPr-POCOP-Ni-Ph
C24H36NiO2P2
Dalton transactions (Cambridge, England : 2003) (2019) 48, 36 13760-13768
a=8.34150(10)Å b=16.5817(3)Å c=9.28950(10)Å
α=90° β=112.390(2)° γ=90°
IPr-POCOP-Pd-0-CB
C20H42B10O2P2Pd
Dalton transactions (Cambridge, England : 2003) (2019) 48, 36 13760-13768
a=13.2661(2)Å b=15.3835(2)Å c=28.9916(3)Å
α=90° β=90° γ=90°
C24H36O2P2Pt
C24H36O2P2Pt
Dalton transactions (Cambridge, England : 2003) (2019) 48, 36 13760-13768
a=8.4272(3)Å b=16.7958(4)Å c=9.4851(3)Å
α=90° β=112.887(4)° γ=90°
NISP
C16H48B20NiP2S2
Dalton transactions (Cambridge, England : 2003) (2019) 48, 36 13760-13768
a=11.4737(2)Å b=9.9192(2)Å c=14.6100(3)Å
α=90° β=100.711(2)° γ=90°
IPr-POCOP-Pt-o-CB
C20H42B10O2P2Pt
Dalton transactions (Cambridge, England : 2003) (2019) 48, 36 13760-13768
a=13.1407(2)Å b=15.2729(2)Å c=28.7118(3)Å
α=90° β=90° γ=90°
Di Ni POCOP iPr CB
C38H72B10Ni2O4P4S2
Dalton transactions (Cambridge, England : 2003) (2019) 48, 36 13760-13768
a=18.7762(6)Å b=15.5899(5)Å c=17.6800(6)Å
α=90° β=90° γ=90°
Cyx
C23H18ClN3O
Chemical communications (Cambridge, England) (2020) 56, 100 15631-15634
a=18.3148(3)Å b=7.58000(10)Å c=27.7096(5)Å
α=90° β=90° γ=90°
C21H19N3O2
C21H19N3O2
Chemical Communications (2019)
a=10.7994(2)Å b=7.81190(10)Å c=19.9950(3)Å
α=90° β=95.7930(10)° γ=90°
C25H25N3O2
C25H25N3O2
Chemical Communications (2019)
a=8.6797(3)Å b=9.9588(4)Å c=23.9097(9)Å
α=90° β=98.219(4)° γ=90°
C32H25NO2S
C32H25NO2S
Chemical communications (Cambridge, England) (2018) 54, 88 12455-12458
a=10.6386(4)Å b=19.7299(5)Å c=12.6060(4)Å
α=90° β=104.558(3)° γ=90°
C14H11BrN2O
C14H11BrN2O
New Journal of Chemistry (2018) 42, 16 13790
a=7.7776(8)Å b=25.3003(11)Å c=16.5229(19)Å
α=90° β=130.314(18)° γ=90°
DAP1
C62H60
Chem.Commun. (2015) 51, 503
a=4.9784(3)Å b=11.3963(7)Å c=19.9225(11)Å
α=95.603(4)° β=92.746(4)° γ=93.200(4)°
DAP2
C86H78
Chem.Commun. (2015) 51, 503
a=9.7359(19)Å b=16.193(3)Å c=22.166(5)Å
α=99.203(10)° β=101.335(12)° γ=101.921(9)°
Cu(I) complex
C6H7Cu2N9O2.50
Chem.Commun. (2015) 51, 10353
a=24.258(5)Å b=9.4877(19)Å c=16.473(3)Å
α=90.00° β=118.79(3)° γ=90.00°
Cu(I)Cu(II) complex
C6H4Cu2N9O1.50
Chem.Commun. (2015) 51, 10353
a=24.338(5)Å b=9.4877(19)Å c=16.502(3)Å
α=90.00° β=119.89(3)° γ=90.00°
Cu(I) complex
C6H8Cu2N9O3
Chem.Commun. (2015) 51, 10353
a=24.321(5)Å b=9.4098(19)Å c=16.628(3)Å
α=90.00° β=119.24(3)° γ=90.00°
Cu(I) complex
C12H19Cu2N10O
Chem.Commun. (2015) 51, 10353
a=24.225(5)Å b=9.6254(19)Å c=16.370(3)Å
α=90.00° β=118.54(3)° γ=90.00°
Bisphenalenethienoacene
C52H54S2Si2
Chem.Commun. (2015) 51, 13178
a=17.7574(16)Å b=14.7085(14)Å c=17.0416(15)Å
α=90° β=90.251(5)° γ=90°
Tetrahexyloxy rubicenoid pentacene
C59H70O5
Chem.Commun. (2015) 51, 3604
a=4.6842(5)Å b=14.8758(15)Å c=17.8030(18)Å
α=107.779(5)° β=94.984(5)° γ=91.886(5)°
Di-tert butyl rubicenoid Pentacene
C43H34O1.5
Chem.Commun. (2015) 51, 3604
a=27.2227(14)Å b=16.4194(8)Å c=6.9476(4)Å
α=90° β=101.7790(18)° γ=90°
N-benzyl-4-methyl-N-(4-methyl-1-oxo-1H-isochromen-3-yl)benzenesulfonamide
C24H21NO4S
Chem.Commun. (2016) 52, 6801
a=10.2840(3)Å b=26.1213(7)Å c=15.8601(4)Å
α=90.00° β=102.6900(10)° γ=90.00°
Cu(I) complex
C12H18Cu2N10O0.50
Chem.Commun. (2015) 51, 10353
a=24.349(5)Å b=9.2334(18)Å c=16.959(3)Å
α=90.00° β=119.41(3)° γ=90.00°
C18H17NO5S
C18H17NO5S
RSC Adv. (2015)
a=8.6539(17)Å b=8.7824(18)Å c=12.894(3)Å
α=100.90(3)° β=90.99(3)° γ=107.77(3)°
C16H16CoN10O4
C16H16CoN10O4
CrystEngComm (2016) 18, 8 1350
a=4.8427(10)Å b=9.4938(19)Å c=20.097(4)Å
α=90.00° β=92.37(3)° γ=90.00°
C16H16MnN10O4
C16H16MnN10O4
CrystEngComm (2016) 18, 8 1350
a=4.9140(10)Å b=9.3923(19)Å c=20.417(4)Å
α=90.00° β=92.66(3)° γ=90.00°
C16H16CdN10O4
C16H16CdN10O4
CrystEngComm (2016) 18, 8 1350
a=4.9534(10)Å b=9.1796(18)Å c=20.865(4)Å
α=90.00° β=93.90(3)° γ=90.00°
C16H16N10O4Pb
C16H16N10O4Pb
CrystEngComm (2016) 18, 8 1350
a=10.487(2)Å b=23.350(5)Å c=8.3772(17)Å
α=90.00° β=90.00° γ=90.00°
C16H28MnN10O10
C16H28MnN10O10
CrystEngComm (2016) 18, 8 1350
a=7.8231(16)Å b=9.0961(18)Å c=9.2962(19)Å
α=94.66(3)° β=107.53(3)° γ=95.54(3)°
C16H28N10NiO10
C16H28N10NiO10
CrystEngComm (2016) 18, 8 1350
a=7.7318(15)Å b=8.9961(18)Å c=9.1815(18)Å
α=94.40(3)° β=107.22(3)° γ=95.01(3)°
C16H28N10O10Zn
C16H28N10O10Zn
CrystEngComm (2016) 18, 8 1350
a=7.7881(16)Å b=9.0380(18)Å c=9.1899(18)Å
α=94.47(3)° β=107.49(3)° γ=95.27(3)°
N-benzyl-4-methyl-N-(1-oxo-4-(p-tolyl)-1H-isochromen-3-yl)benzenesulfonamide
C30H25NO4S
Chem.Commun. (2016) 52, 6801
a=12.2963(4)Å b=13.8393(4)Å c=16.8203(4)Å
α=71.7040(10)° β=82.1800(10)° γ=66.1200(10)°
C32H42Cu2N20O13
C32H42Cu2N20O13
CrystEngComm (2016) 18, 8 1350
a=8.2134(16)Å b=16.974(3)Å c=19.396(6)Å
α=90.00° β=101.13(3)° γ=90.00°
C16H28CoN10O10
C16H28CoN10O10
CrystEngComm (2016) 18, 8 1350
a=7.7702(16)Å b=9.0412(18)Å c=9.2461(18)Å
α=94.47(3)° β=107.46(3)° γ=95.08(3)°
[Fe7O2(OH)6(oxyme)3(Py)6][BF4]5.14(MeOH).6(H2O)
[Fe7O2(OH)6(oxyme)3(Py)6][BF4]5.14(MeOH).6(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 29 8777-8785
a=16.9480(11)Å b=32.864(2)Å c=31.135(2)Å
α=90° β=94.336(4)° γ=90°
[Fe6O(OH)7(oxime)3][BF4]3.4H2O.9MeOH
[Fe6O(OH)7(oxime)3][BF4]3.4H2O.9MeOH
Dalton transactions (Cambridge, England : 2003) (2012) 41, 29 8777-8785
a=26.5317(4)Å b=26.5317(4)Å c=101.306(2)Å
α=90° β=90° γ=120°
[Mn6O2(Oxyme)3(Py)4(MeCN)2(OH)2(NO3)][BF4]5.3MeCN.1H2O.5Py
[Mn6O2(Oxyme)3(Py)4(MeCN)2(OH)2(NO3)][BF4]5.3MeCN.1H2O.5Py
Dalton transactions (Cambridge, England : 2003) (2012) 41, 29 8777-8785
a=32.9404(6)Å b=18.7090(3)Å c=28.3771(5)Å
α=90° β=111.947(2)° γ=90°
C48H37Ca3N2O15P2
C48H37Ca3N2O15P2
Chem.Commun. (2011) 47, 11855
a=23.476(5)Å b=9.5054(19)Å c=27.629(6)Å
α=90.00° β=90.00° γ=90.00°
C32H29NO6S
C32H29NO6S
Organic letters (2016) 18, 19 5022-5025
a=11.544(2)Å b=14.011(3)Å c=17.128(3)Å
α=90.00° β=99.02(3)° γ=90.00°
C20H30HgN6O2S2,2(NO3)
C20H30HgN6O2S2,2(NO3)
Acta Crystallographica Section E (2005) 61, 10 m2100-m2102
a=19.758(4)Å b=13.580(3)Å c=11.587(3)Å
α=90.00° β=115.739(3)° γ=90.00°
Bis[1-hydroxy-4,4,5,5-tetramethyl-2-(1,3-thiazol-2-yl)-4,5-dihydro- 1H-imidazole]nitratocobalt(II) nitrate
C20H30CoN7O5S2,NO3
Acta Crystallographica Section E (2005) 61, 11 m2230-m2231
a=13.1701(8)Å b=10.4625(6)Å c=10.6961(7)Å
α=90.00° β=90.00° γ=90.00°
3-(4'-methyl)-phenyl-5-(3'-indolyl)-isoxazoline
C18H16N2O
Acta Crystallographica Section E (2006) 62, 1 o374-o375
a=8.1881(19)Å b=12.713(3)Å c=14.239(3)Å
α=90.00° β=90.00° γ=90.00°
3,4,5-Trimethoxyphenyl 4-bromo-7-methoxy-1,3-benzodioxole-5-carboxylate
C18H17BrO8
Acta Crystallographica Section E (2005) 61, 8 o2508-o2509
a=8.6563(16)Å b=7.6330(12)Å c=26.927(4)Å
α=90.00° β=95.403(9)° γ=90.00°
1-(2-hydroxy-3,5-dimethylphenyl)ethanone
C10H12O2
Acta Crystallographica Section E (2006) 62, 10 o4329-o4330
a=14.46(2)Å b=8.076(15)Å c=16.03(3)Å
α=90.00° β=109.05(2)° γ=90.00°
N-(2,4-Dimethylphenyl)benzenesulfonamide
C14H15NO2S
Acta Crystallographica Section E (2007) 63, 9 o3670-o3670
a=7.999(3)Å b=11.073(4)Å c=15.116(5)Å
α=90.00° β=96.822(6)° γ=90.00°
2-{(1E)-1-[(4-Chlorophenyl)imino]ethyl}-4-methylphenol
C15H14ClNO
Acta Crystallographica Section E (2007) 63, 11 o4328-o4328
a=13.254(6)Å b=8.285(3)Å c=12.078(6)Å
α=90.00° β=95.640(9)° γ=90.00°
1-(2-Hydroxy-5-methylphenyl)-2-phenylethanone
C15H14O2
Acta Crystallographica Section E (2007) 63, 9 o3810-o3810
a=8.2951(10)Å b=18.010(2)Å c=8.9186(10)Å
α=90.00° β=114.103(4)° γ=90.00°
4-methoxy-N-[(1E)-(2-nitrophenyl)methylene]benzhydrazide
C15H13N3O4
Acta Crystallographica Section E (2007) 63, 10 o3997-o3997
a=27.3272(15)Å b=4.8389(3)Å c=21.6639(12)Å
α=90.00° β=90.00° γ=90.00°
(E,E)-4,4'-Dichloro-2,2'-(1,1'-azinodiethylene)diphenol
C16H14Cl2N2O2
Acta Crystallographica Section E (2007) 63, 10 o3982-o3982
a=3.9105(2)Å b=6.2985(4)Å c=15.1479(9)Å
α=89.520(2)° β=88.7920(10)° γ=86.164(2)°
(E,E)-4,4'-Dimethyl-2,2'-(1,1'-dibenzylazino)diphenol
C30H28N2O2
Acta Crystallographica Section E (2007) 63, 10 o4061-o4061
a=7.7881(3)Å b=9.3199(4)Å c=16.5419(6)Å
α=90.00° β=98.388(2)° γ=90.00°
N'-[(1E)-(3,5-Dichloro-2-hydroxyphenyl)(phenyl)methylene]-4- methoxybenzohydrazide
C21H15Cl2N2O3
Acta Crystallographica Section E (2008) 64, 1 o198-o198
a=8.9814(9)Å b=10.8867(11)Å c=11.5291(13)Å
α=89.623(2)° β=72.7000(10)° γ=66.947(2)°
N'-[(1E)-(5-Chloro-2-hydroxyphenyl)(phenyl)methylene]-2-hydroxybenzohydrazide
C20H15ClN2O3
Acta Crystallographica Section E (2007) 63, 2 o474-o475
a=15.3237(6)Å b=12.0171(5)Å c=20.0773(8)Å
α=90.00° β=90.00° γ=90.00°
N'-[(1E)-1-(2-Hydroxy-5-methylphenyl)ethylidene]-4-methoxybenzohydrazide
C17H18N2O3
Acta Crystallographica Section E (2007) 63, 7 o3212-o3212
a=15.2171(13)Å b=4.9253(4)Å c=20.0906(16)Å
α=90.00° β=93.021(3)° γ=90.00°
(E,E)-1,4-Diethyl-1,4-Di-(5-chloro-2-hydroxyphenyl)-2,3-diazabutadiene
C18H18Cl2N2O2
Acta Crystallographica Section E (2007) 63, 7 o3297-o3297
a=9.3706(3)Å b=13.9089(4)Å c=6.7640(2)Å
α=90.00° β=103.0210(10)° γ=90.00°
(2-hydroxy-5-methylphenyl)(phenyl)methanone
C14H12O2
Acta Crystallographica Section E (2007) 63, 8 o3517-o3517
a=15.9176(7)Å b=5.8509(2)Å c=12.1429(5)Å
α=90.00° β=105.745(2)° γ=90.00°
(<i>E</i>,<i>E</i>)-4,4',6,6'-Tetrachloro-2,2'-(1,1'-azinodiethylene)diphenol
C18H16Cl4N2O2
Acta Crystallographica Section E (2007) 63, 8 o3382-o3382
a=7.8251(5)Å b=8.0294(4)Å c=8.3899(5)Å
α=65.894(2)° β=80.961(4)° γ=74.821(2)°
N'-[(1E)-(5-chloro-2-hydroxyphenyl)(phenyl)methylene]-4- methoxybenzohydrazide
C21H17ClN2O3
Acta Crystallographica Section E (2007) 63, 10 o4022-o4022
a=9.2861(19)Å b=13.026(3)Å c=15.722(3)Å
α=90.00° β=102.089(8)° γ=90.00°
2-Hydroxy-N'-[(1Z)-1-(2-hydroxy-5-methylphenyl)-2- methylpropylidene]benzohydrazide
C18H20N2O3
Acta Crystallographica Section E (2008) 64, 1 o197-o197
a=11.2144(11)Å b=11.2887(11)Å c=13.6535(13)Å
α=90.00° β=107.000(2)° γ=90.00°
(+-)-2,4-Dichloro-6-{(RS)-phenyl[(1RS)-1,2,3,4- tetrahydronaphthalen-1-ylamino]methyl}phenol
C23H21Cl2NO
Acta Crystallographica Section E (2006) 62, 11 o5288-o5289
a=9.3022(8)Å b=10.0796(8)Å c=12.4308(16)Å
α=106.943(2)° β=107.763(2)° γ=103.657(2)°
4-Chloro-2-{[(R)-(3'S,8'R)-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d][1,3]oxazol- 3-yl](phenyl)methyl}phenol
C23H20ClNO2
Acta Crystallographica Section E (2006) 62, 9 o4078-o4079
a=9.5270(12)Å b=18.657(2)Å c=22.679(3)Å
α=90.00° β=90.00° γ=90.00°
2-Hydroxy-N'-[(1E)-1-(2-hydroxy-5-methylphenyl)-2- phenylethylidene]benzohydrazide
C22H20N2O3
Acta Crystallographica Section E (2006) 62, 12 o5527-o5528
a=6.7401(11)Å b=10.4033(17)Å c=14.065(2)Å
α=79.475(6)° β=80.193(6)° γ=78.639(6)°
<i>N</i>,<i>N</i>-Dimethylacetamide--4-iodobenzenesulfonic acid--water (1/1/1)
C6H5IO3S,C4H9NO,H2O
Acta Crystallographica Section E (2008) 64, 12 o2376
a=14.173(3)Å b=7.7480(15)Å c=13.272(3)Å
α=90.00° β=90.00° γ=90.00°
1,4-Dibromo-2,5-dimethoxybenzene
C8H8Br2O2
Acta Crystallographica Section E (2010) 66, 7 o1806
a=6.5730(10)Å b=8.438(2)Å c=8.756(2)Å
α=90.00° β=90.14(3)° γ=90.00°
12b-acetoxy-12-(3-fluorobenzoyloxy)-4,6-bis(2,2,2-trichloroethoxycarbonyl)- 1,2a,3,4,4a,6,9,10,11,12,12a,12b-decahydro-9,11-dihydroxy-4a,8,13,13- tetramethyl-7,11-methano-5<i>H</i>-cyclodeca[3,4]benz[1,2-<i>b</i>]oxet-5-one monohydrate ethyl acetate monosolvate
C35H37Cl6FO14,C4H8O3,H2O1
Acta Crystallographica Section E (2011) 67, 3 o547
a=14.7037(11)Å b=16.6601(12)Å c=18.9258(14)Å
α=90.00° β=90.00° γ=90.00°
(3<i>R</i>,4<i>S</i>)-1-(4-Methoxyphenyl)-2-oxo-4-(3-vinylphenyl)azetidin-3-yl acetate
C20H19NO4
Acta Crystallographica Section E (2013) 69, 4 o601
a=20.7448(4)Å b=6.39300(10)Å c=15.7434(3)Å
α=90.00° β=124.3090(10)° γ=90.00°
Br2Cu,C8H20N
Br2Cu,C8H20N
ACS applied materials & interfaces (2019) 11, 19 17513-17520
a=8.3505(8)Å b=13.7641(13)Å c=11.0507(11)Å
α=90° β=97.076(9)° γ=90°